Clinical Trial Update: Botulinum Toxin is a Potential Prophylactic Therapy for Minimizing Post-excisional Scarring (Allergan Botox Scar Study) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating botulinum toxin as a potential prophylactic therapy to minimize post-excisional scarring; trial completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-operative Excessive Scarring
• Postoperative Scar

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Post-operative Excessive Scarring | Phase 2 | Status: COMPLETED | Results posted: 2020-11-13